BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29469148)

  • 1. Advances in point-of-care diagnostic devices in cancers.
    Sandbhor Gaikwad P; Banerjee R
    Analyst; 2018 Mar; 143(6):1326-1348. PubMed ID: 29469148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Liquid Biopsy Using Integrated Microfluidic Exosome Analysis Platforms.
    Li G; Tang W; Yang F
    Biotechnol J; 2020 May; 15(5):e1900225. PubMed ID: 32032977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.
    Shadfan BH; Simmons AR; Simmons GW; Ho A; Wong J; Lu KH; Bast RC; McDevitt JT
    Cancer Prev Res (Phila); 2015 Jan; 8(1):37-48. PubMed ID: 25388014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in point-of-care technologies for molecular diagnostics.
    Zarei M
    Biosens Bioelectron; 2017 Dec; 98():494-506. PubMed ID: 28728010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of point-of-care nanobiosensors for breast cancers diagnosis.
    Sharifi M; Hasan A; Attar F; Taghizadeh A; Falahati M
    Talanta; 2020 Sep; 217():121091. PubMed ID: 32498898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker detection for disease diagnosis using cost-effective microfluidic platforms.
    Sanjay ST; Fu G; Dou M; Xu F; Liu R; Qi H; Li X
    Analyst; 2015 Nov; 140(21):7062-81. PubMed ID: 26171467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance modified cellulose paper-based biosensors for medical diagnostics and early cancer screening: A concise review.
    Ratajczak K; Stobiecka M
    Carbohydr Polym; 2020 Feb; 229():115463. PubMed ID: 31826408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microfluidic-integrated biosensors: prospects for point-of-care diagnostics.
    Kumar S; Kumar S; Ali MA; Anand P; Agrawal VV; John R; Maji S; Malhotra BD
    Biotechnol J; 2013 Nov; 8(11):1267-79. PubMed ID: 24019250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shifting paradigm of cancer diagnoses in clinically relevant samples based on miniaturized electrochemical nanobiosensors and microfluidic devices.
    Mahato K; Kumar A; Maurya PK; Chandra P
    Biosens Bioelectron; 2018 Feb; 100():411-428. PubMed ID: 28957706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidic toner-based analytical devices: disposable, lightweight, and portable platforms for point-of-care diagnostics with colorimetric detection.
    Oliveira KA; de Souza FR; de Oliveira CR; da Silveira LA; Coltro WK
    Methods Mol Biol; 2015; 1256():85-98. PubMed ID: 25626533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in diagnostic microfluidics.
    Burklund A; Tadimety A; Nie Y; Hao N; Zhang JXJ
    Adv Clin Chem; 2020; 95():1-72. PubMed ID: 32122520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic paper-based analytical devices for potential use in quantitative and direct detection of disease biomarkers in clinical analysis.
    Lim WY; Goh BT; Khor SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():424-442. PubMed ID: 28683395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-care cancer diagnostic devices: From academic research to clinical translation.
    Syedmoradi L; Norton ML; Omidfar K
    Talanta; 2021 Apr; 225():122002. PubMed ID: 33592810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Dimensional Nanostructures for Microfluidic Screening of Biomarkers: From Molecular Separation to Cancer Cell Detection.
    Ng E; Chen K; Hang A; Syed A; Zhang JX
    Ann Biomed Eng; 2016 Apr; 44(4):847-62. PubMed ID: 26692080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfluidics at the crossroad with point-of-care diagnostics.
    Linder V
    Analyst; 2007 Dec; 132(12):1186-92. PubMed ID: 18318278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid biosensing tools for cancer biomarkers.
    Ranjan R; Esimbekova EN; Kratasyuk VA
    Biosens Bioelectron; 2017 Jan; 87():918-930. PubMed ID: 27664412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging trends in nanomaterial design for the development of point-of-care platforms and practical applications.
    Moulahoum H; Ghorbanizamani F; Beduk T; Beduk D; Ozufuklar O; Guler Celik E; Timur S
    J Pharm Biomed Anal; 2023 Oct; 235():115623. PubMed ID: 37542827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and opportunities for translating medical microdevices: insights from the programmable bio-nano-chip.
    McRae MP; Simmons G; McDevitt JT
    Bioanalysis; 2016 May; 8(9):905-19. PubMed ID: 27071710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorimetric Paper-Based Sensors against Cancer Biomarkers.
    Carneiro MCCG; Rodrigues LR; Moreira FTC; Sales MGF
    Sensors (Basel); 2022 Apr; 22(9):. PubMed ID: 35590912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer.
    Rusling JF; Kumar CV; Gutkind JS; Patel V
    Analyst; 2010 Oct; 135(10):2496-511. PubMed ID: 20614087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.